相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Increased Coronary Heart Disease Risk Determined by High High-Density Lipoprotein Cholesterol and C-Reactive Protein: Modulation by Variation in the CETP Gene
Robin P. F. Dullaart
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
High plasma lecithin: cholesterol acyltransferase activity does not predict low incidence of cardiovascular events: Possible attenuation of cardioprotection associated with high HDL cholesterol
Robin P. F. Dullaart et al.
ATHEROSCLEROSIS (2010)
Inflammation reduces HDL protection against primary cardiac risk
James P. Corsetti et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2010)
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
John H. Contois et al.
CLINICAL CHEMISTRY (2009)
High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus
Robin P. F. Dullaart et al.
CLINICAL ENDOCRINOLOGY (2009)
Targets for LDL-lowering therapy
Allan Sniderman
CURRENT OPINION IN LIPIDOLOGY (2009)
The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls
Sarah Parish et al.
EUROPEAN HEART JOURNAL (2009)
Atorvastatin affects low density lipoprotein and non-high density lipoprotein cholesterol relations with apolipoprotein B in type 2 diabetes mellitus: modification by triglycerides and cholesteryl ester transfer protein
Paul J. W. H. Kappelle et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Major Lipids, Apolipoproteins, and Risk of Vascular Disease
The Emerging Risk Factors Collaboration*
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Association of c-reactive protein and microalbuminuria (from the national health and nutrition examination surveys, 1999 to 2004)
Abhijit V. Kshirsagar et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Albuminuria Assessed From First-Morning-Void Urine Samples Versus 24-Hour Urine Collections as a Predictor of Cardiovascular Morbidity and Mortality
Hiddo J. Lambers Heerspink et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Mild elevations of urine albumin excretion are associated with atherogenic lipoprotein abnormalities in the Multi-Ethnic Study of Atheroslcerosis (MESA)
Ian H. de Boer et al.
ATHEROSCLEROSIS (2008)
Lipids, apolipoproteins, and their ratios in relation to cardiovascular events with statin treatment
John J. P. Kastelein et al.
CIRCULATION (2008)
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: Significance for cardiovascular risk - The IDEAL and EPIC-Norfolk studies
Wim A. van der Steeg et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Statin therapy alters the relationship between apolipoprotein B and low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol targets in high-risk patients - The MERCURY II (Measuring Effective Reductions in Cholesterol Using Rosuvastatin therapY II) trial
Christie M. Ballantyne et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Lipoprotein management in patients with cardiometabolic risk - Consensus conference report from the American diabetes association and the American college of cardiology foundation
John D. Brunzell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study
Matthew J. McQueen et al.
LANCET (2008)
Apolipoprotein A-II is inversely associated with risk of future coronary artery disease
Rakesh S. Birjmohun et al.
CIRCULATION (2007)
Role of the apolipoprotein B-apolipoprotein A-I ratio in cardiovascular risk assessment: A case--control analysis in EPIC-Norfolk
Wim A. van der Steeg et al.
ANNALS OF INTERNAL MEDICINE (2007)
Improving prediction of ischemic cardiovascular disease in the general population using apolipoprotein B -: The Copenhagen city heart study
Marianne Benn et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2007)
Higher plasma leptin largely explains increased C-reactive protein levels in women
R. P. F. Dullaart et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2007)
An increased coronary risk is paradoxically associated with common cholesteryl ester transfer protein gene variations that relate to higher high-density lipoprotein cholesterol: A population-based study
Susanna E. Borggreve et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Microalbuminuria and risk for cardiovascular disease: Analysis of potential mechanisms
Coen D. A. Stehouwer et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2006)
Myeloperoxidase: an inflammatory enzyme for generating dysfunctional high density lipoprotein
Baohai Shao et al.
CURRENT OPINION IN CARDIOLOGY (2006)
Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel
PJ Barter et al.
JOURNAL OF INTERNAL MEDICINE (2006)
Functionally defective high-density lipoprotein: A new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis
Anatol Kontush et al.
PHARMACOLOGICAL REVIEWS (2006)
Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men
T Pischon et al.
CIRCULATION (2005)
Urinary albumin excretion and its relation with C-reactive protein and the metabolic syndrome in the prediction Of type 2 diabetes
AH Brantsma et al.
DIABETES CARE (2005)
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals -: The Framingham heart study
J Ärnlöv et al.
CIRCULATION (2005)
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women
PM Ridker et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
C-reactive protein modifies the relationship between blood pressure and microalbuminuria
EM Stuveling et al.
HYPERTENSION (2004)
Apolipoprotein B and apolipoprotein A-I: risk indicators of coronary heart disease and targets for lipid-modifying therapy
G Walldius et al.
JOURNAL OF INTERNAL MEDICINE (2004)
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure - The JNC 7 Report
AV Chobanian et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Diabesity: An inflammatory metabolic condition
MI Schmidt et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2003)
Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men
PJ Talmud et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population
HL Hillege et al.
CIRCULATION (2002)
High apolipoprotein B, low apolipoprotein A-I, and improvement in the prediction of fatal myocardial infarction (AMORIS study): a prospective study
G Walldius et al.
LANCET (2001)
Apolipoproteins A-I, A-II and B, lipoprotein(a) and the risk of ischaemic heart disease: the Caerphilly Study
PM Sweetnam et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2000)
分享论文
